The parametric g-formula for time-to-event data: Intuition and a worked example

Epidemiology

Volumn 25, Issue 6, 2014, Pages 889-897

  Keil, Alexander P ^a   Edwards, Jessie K ^a   Richardson, David B ^a   Naimi, Ashley I ^b   Cole, Stephen R ^a  

^a IL   (United States)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG;

ADULT; ALGORITHM; ALLOGENIC BONE MARROW TRANSPLANTATION; ANALYTIC METHOD; ARTICLE; ATTRIBUTABLE RISK; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; EXPOSURE VARIABLE; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HAZARD RATIO; HUMAN; IMMUNE STATUS; LEUKEMIA; LEUKEMIA RELAPSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY (TOPIC); PARAMETRIC G FORMULA; PRIORITY JOURNAL; PROBABILITY; PUBLIC HEALTH; STANDARDIZATION; STATISTICAL ANALYSIS; SURVIVAL RATE; THROMBOCYTE COUNT; TIME; BONE MARROW TRANSPLANTATION; CAUSE OF DEATH; EPIDEMIOLOGY; GRAFT VS HOST DISEASE; MONTE CARLO METHOD;

ADULT; ALGORITHMS; BONE MARROW TRANSPLANTATION; CAUSE OF DEATH; CONFOUNDING FACTORS (EPIDEMIOLOGY); EPIDEMIOLOGIC METHODS; FEMALE; GRAFT VS HOST DISEASE; HUMANS; MALE; MONTE CARLO METHOD; MULTICENTER STUDIES AS TOPIC; PROBABILITY;

EID: 84924052633     PISSN: 10443983     EISSN: 15315487     Source Type: Journal    
DOI: 10.1097/EDE.0000000000000160     Document Type: Article

References (40)

1. Sullivan K, Weiden P, Storb R, et al. Influence of acute and chronic graftversus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia [published erratum appears in Blood 1989 Aug. 15; 74(3):1180]. Blood. 1989;73:1720-1728.
2. Horowitz MM, Gale RP, Sondel PM, et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood. 1990;75:555-562.
3. Robins JM, Wasserman L. Estimation of effects of sequential treatments by reparameterizing directed acyclic graphs. In: Geiger D, Shenoy P, eds. Proceedings of the Thirteenth Conference on Uncertainty in Artificial Intelligence. San Francisco, CA: Morgan Kaufmann: 1997;409-420.
4. Keiding N, Filiberti M, Esbjerg S, Robins JM, Jacobsen N. The graft versus leukemia effect after bone marrow transplantation: a case study using structural nested failure time models. Biometrics. 1999;55:23-28.
5. Hernán MA, Robins JM. Causal Inference. Boca Raton, Fla: Chapman & Hall/CRC; 2013.
6. Rosenbaum PR. The consequences of adjustment for a concomitant variable that has been affected by the treatment. J R Stat Soc Ser A-G. 1984;147:656-666.
7. Weinberg CR. Toward a clearer definition of confounding. Am J Epidem iol. 1993;137:1-8.
8. Robins JM. A new approach to causal inference in mortality studies with a sustained exposure period-application to control of the healthy worker survivor effect. Math Mod. 1986;7:1393-1512.
9. Hernán MA, Robins JM. Estimating causal effects from epidemiological data. J Epidemiol Community Health. 2006;60:578-586.
10. Robins JM. A graphical approach to the identification and estimation of causal parameters in mortality studies with sustained exposure periods. J ChronDis. 1987;40:139S-161S.
11. Ahern J, Hubbard A, Galea S. Estimating the effects of potential public health interventions on population disease burden: a step-by-step illustration of causal inference methods. Am J Epidemiol. 2009;169:1140-1147.
12. Taubman SL, Robins JM, Mittleman MA, Hernán MA. Intervening on risk factors for coronary heart disease: an application of the parametric g-formula. Int J Epidemiol. 2009;38:1599-1611.
13. Young JG, Cain LE, Robins JM, O'Reilly EJ, Hernán MA. Comparative effectiveness of dynamic treatment regimes: an application of the parametric g-formula. Stat Biosci. 2011;3:119-143.
14. Westreich D, Cole SR, Ymng JG, et al. The parametric g-formula to estimate the effect of highly active antiretroviral therapy on incident AIDS or death. Stat Med. 2012;31:2000-2009.
15. Cole SR, Richardson DB, Chu H, Naimi Al. Analysis of occupational asbestos exposure and lung cancer mortality using the g formula. Am J Epidemiol. 2013;177:989-996.
16. Danaei G, Pan A, Hu FB, Hernán MA. Hypothetical midlife interventions in women and risk of type 2 diabetes. Epidemiology. 2013;24:122-128.
17. Garcia-Aymerich J, Varraso R, Danaei G, Camargo CA Jr, Hernán MA. Incidence of adult-onset asthma after hypothetical interventions on body mass index and physical activity: an application of the parametric g-formula. Am J Epidemiol. 2014;179:20-26.
18. Robins JM, Hernán MA, Siebert U. Effects of multiple interventions. In: Ezzati M, Lopez AD, Rodgers A, and Murray CJL, eds. Comparative Quantification of Health Risks: The Global and Regional Burden of Disease Attributable to Major Risk Factors. Geneva, Switzerland: World Health Organization; 2004.
19. Copelan EA, Biggs JC, Thompson JM, et al. Treatment for acute myelocytic leukemia with allogeneic bone marrow transplantation following preparation with BuCy2. Blood. 1991;78:838-843.
20. Klein JP, Moeschberger ML. Examples of survival data. In: Dietz K, Gail M, Krickeberg GK, Samet J, and Tsiatis A, eds. Survival Analysis: Techniques for Censored and Truncated Data. 2nd ed. New York: Springer; 2003:1-21.
21. D'Agostino RB, Lee ML, Belanger AJ, Cupples LA, Anderson K, Kannel WB. Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study. Stat Med. 1990;9:1501-1515.
22. Therneau TM, Grambsch PM. Modeling Survival Data: Extending the Cox Model. New York: Springer; 2000.
23. Schisterman EF, Cole SR, Platt RW. Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology. 2009;20:488-495.
24. Cole SR, Hernán MA. Fallibility in estimating direct effects. Int J Epidemiol. 2002;31:163-165.
25. Hernán MA. The hazards of hazard ratios. Epidemiology. 2010;21:13-15.
26. Greenland S. Absence of confounding does not correspond to collapsibility of the rate ratio or rate difference. Epidemiology. 1996;7:498-501.
27. Cole SR, Hernán MA, Robins JM, et al. Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models. Am J Epidemiol. 2003;158:687-694.
28. Hernán MA, Cole SR, Margolick J, Cohen M, Robins JM. Structural accelerated failure time models for survival analysis in studies with timevarying treatments. Pharmacoepidemiol Drug Saf. 2005;14:477-491.
29. Cole SR, Hernán MA. Constructing inverse probability weights for marginal structural models. Am J Epidemiol. 2008;168:656-664.
30. Daniel RM, Cousens SN, De Stavola BL, Kenward MG, Sterne JA. Methods for dealing with time-dependent confounding. Stat Med. 2013;32:1584-1618.
31. Robins JM. Marginal structural models versus structural nested models as tools for causal inference. In: Halloran MS, Berry D, eds. Statistical Models in Epidemiology: The Environment and Clinical Trials. IMA Vol 116. 1999:95-134.
32. Lash TL, Fox MP, Fink AK. Applying Quantitative Bias Analysis to Epidemiologic Data. New York: Springer Verlag; 2009.
33. Cole SR, Frangakis CE. The consistency statement in causal inference: a definition or an assumption? Epidemiology. 2009;20:3-5.
34. Hernán MA, Vander Weele TJ. Compound treatments and transportability of causal inference. Epidemiology. 2011;22:368-377.
35. Hernán MA, Taubman SL. Does obesity shorten life? The importance of well-defined interventions to answer causal questions. Int JObes (Lond). 2008;32 Suppl 3:S8-14.
36. Robins JM. The analysis of randomized and non-randomized AIDS treatment trials using a new approach to causal inference in longitudinal studies. In: Sechrest L, Freeman H, Mulley A, eds. Health Service Research Methodology: A Focus on AIDS. 1989:113-159.
37. Robins JM, Tsiatis A A. Semiparametric estimation of an accelerated failure time model with time-dependent covariates. Biometrika. 1992;79:311-319.
38. Robins JM, Hernán MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000;11:550-560.
39. Westreich D, Cole SR. Invited commentary: positivity in practice. Am J Epidemiol. 2010;171:674-677.
40. Joffe MM, Yang WP, Feldman H. G-estimation and artificial censoring: problems, challenges, and applications. Biometrics. 2012;68:275-286.